Chelsea, Barcelona draw as Bayern hammer Besiktas

Lionel Messi scored his first goal against Chelsea to earn Barcelona a 1-1 draw in the first leg of their Champions League last-16 clash at Stamford Bridge last night as Bayern Munich beat 10-man Besiktas 5-0 to equal their longest winning run of 14 matches and take a convincing lead in their Champions League last-16 tie.   

Chelsea and Barcelona were facing each other for the 13th time in the Champions League, renewing their rivalry after a classic semi-final clash in 2012.

Willian hit the post twice but finally found the net in the 62nd minute with what looked to be the winning goal, only for Messi to score a goal in the 75th minute for the first time in six games against Chelsea to earn a 1-1 draw.

The second leg takes place at the Nou Camp on Wednesday, March 14.

The result does mean none of the English teams have lost in their last-16 first-leg ties so far.

Liverpool beat Porto 5-0, Manchester City defeated Basel 4-0, Tottenham drew 2-2 at Juventus. Manchester United visit Sevilla on Wednesday.

Meanwhile, Bayern Munich put five past 10-man Besiktas to equal their longest winning run and take a convincing lead in their Champions League last-16 tie.

The hosts won their 14th consecutive game after a dominant second half against Besiktas, who had Domagoj Vida sent off after 16 minutes.

Thomas Muller and Robert Lewandowski scored two goals as Kingsley Coman scored one goal to give Bayern an advantage going into the second leg which will be played at the Vodafone Park on march 14.

Other champions league matches will be staged tonight, Manchester united will travel to Sevilla as Shakhtar Donetsk welcomes As Roma.

  

Latest posts

Odibets gifts Ferdinand Omanyala brand new car

Margaret Kalekye

Samuel Eto’o announces candidacy for presidency of Cameroon football federation

Bernard Okumu

FC Talanta signs 3 year sponsorship deal with betting firm 10bet

Hunja Macharia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More